Platelet activation occurs in patients with allergic inflammation, and platelets can be activated directly by allergen via an IgE-dependent process. Platelets have been shown to activate APCs such as CD11c 1 dendritic cells in vitro. Although CD11c 1 dendritic cells are a requisite for allergen sensitization, the role of platelets in this process is unknown. In this study, we investigated whether platelets were necessary for allergen sensitization. Balb/c mice sensitized to ovalbumin were exposed to subsequent aerosolized allergen (ovalbumin challenge). We analyzed lung CD11c 1 cell activation, colocalization with platelets, and some other indices of inflammation. The role of platelets at the time of allergen sensitization was assessed through platelet depletion experiments restricted to the period of sensitization. Platelets colocalized with airway CD11c 1 cells, and this association increased after allergen sensitization as well as after subsequent allergen exposure. Temporary platelet depletion (.95%) at the time of allergen sensitization led to a suppression of IgE and IL-4 synthesis and to a decrease in the pulmonary recruitment of eosinophils, macrophages, and lymphocytes after subsequent allergen exposure. Furthermore, in mice previously depleted of platelets at the time of sensitization, the recovered platelet population was shown to have reduced expression of FceRI. Pulmonary CD11c 1 cell recruitment was suppressed in these mice after allergen challenge, suggesting that the migration of CD11c 1 cells in vivo may be dependent on direct platelet recognition of allergen. We conclude that platelets are necessary for efficient host sensitization to allergen. This propagates the subsequent inflammatory response during secondary allergen exposure and increases platelet association with airway CD11c 1 cells.
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Clinical Relevance
This research will impact clinicians' research on platelet activation in patients with asthma and on cellular mechanisms involved in allergen sensitization. It adds to current knowledge of platelet activation by allergen during initial sensitization.
Platelet activation in allergic diseases such as asthma has been reported extensively over the last 30 years, with evidence of changes in platelet volume, presence of platelet microparticles, release of platelet-specific inflammatory mediators, and an increased incidence of circulating platelet-leukocyte (including eosinophil) complexes, both in patients undergoing spontaneous asthma attacks and in patients after allergen challenge (1) (2) (3) (4) . Furthermore, platelet activation correlates strongly to changes in lung function (4) (5) (6) (7) (8) (9) . Various in vivo studies confirm that the activation of platelets during allergy and asthma plays a central role in the inflammatory response (3, (10) (11) (12) (13) . Of significance, pulmonary platelet recruitment and accumulation occur in the lungs, initially via an IgE-dependent process whereby platelets migrate and enter the extravascular space (7, (14) (15) (16) (17) . The significance and temporal nature of allergen-induced activation of platelets via FceRI has not been established; yet, of pertinence to allergy, platelets from patients allergic to Dermatophagoides pteronyssinus have been shown to be activated directly by the specific allergen, or by synthetic peptides derived from the allergen, through an IgE-dependent process (16, 18) . Combined, these studies argue for a causal role of platelet activation in asthma and allergy and that such activation is not a consequence of the inflammatory milieu per se. In addition, it has been shown that platelet-derived serotonin is important for dendritic cell (DC) activation during allergic airway inflammation, further supporting a role for platelets and suggesting that the activation and migration of platelets induced by allergen might be of significance or causal to the sensitization process (19) . Myeloid dendritic cells are believed to be involved very early in the development of asthma by inducing sensitization to inhaled antigen, and they are increasingly viewed as essential proinflammatory cells that induce effector cytokine production in primed T-helper cell type 2 (Th2) cells during airway inflammation (20) (21) (22) (23) . It is therefore of interest that platelet CD40L has recently been reported to be involved in the promotion of allergic airway inflammation by polarizing Th2 responses after allergen exposure (24) . We have previously demonstrated a presence of platelets extravascularly in the lungs of mice before subsequent allergen exposure in allergen-sensitized mice, but the vast majority of these platelets were attached to a resident undefined mononuclear cell population, and the relevance of this occurrence has yet to be established (16) . We hypothesized that these platelets are a distinct population that had migrated to the lungs as a result of exposure to allergen (i.p. injection of ovalbumin [OVA] ) and that a population of platelets might therefore be involved in initial sensitization to allergen. Temporally, the occurrence was clearly unrelated to subsequent aerosolized exposures to allergen (OVA), which drives platelet migration into the lungs together with recruited leukocytes (16) . We report that CD11c 1 cells (as a marker for DCs) are decorated with platelets during allergen sensitization, and we investigate the importance of these platelets during the process of allergen sensitization and their interactions with CD11c 1 cells before and during subsequent exposure to aerosolized allergen. These studies provide a possible role for the specific activation of platelets by allergen from patients with asthma and the occurrence of platelets in the lungs of patients with asthma. 
Methods

Platelet Depletion
To produce profound but temporary platelet depletion for the selective period of allergen sensitization, groups of mice were administered intramuscularly (50-ml i.m. injection into a hind limb) 25 mg per mouse antiplatelet antibody (antiglycoprotein Iba; Emfret Technologies) or control IgG (monoclonal 2A3 antitrinitrophenol; Bio X Cell) 24 hours before allergen sensitizations on Days 21 and 6. Previous studies in our laboratory have demonstrated that mice receiving this antiplatelet antibody do not display pulmonary edema, hemorrhage, or weight loss beyond 10% body weight.
Statistical Analysis
The experimenters were blinded to the identity of experimental groups for the manual quantification of tissue samples/cells. Data from allergic animal studies are presented as mean 6 SEM and were analyzed by one-way analysis of variance followed by Bonferroni's multiple comparisons posttest. A P value less than 0.05 was considered significant.
Results
CD11c
1 Cell and Platelet Colocalization Occurs in the Airways during Sensitization to Allergen Platelets, in low numbers, have previously been observed adjacent to mononuclear cells in lungs of mice before allergen exposure (16) . To identify these cells and to quantify the extent of platelet decoration, lung sections were stained for CD11c using an antimouse anti-CD11c antibody (green, indicated by white arrow in Figure 1A ) as a marker for DCs (26) and stained for the presence of platelets using an antimouse anti-CD41 antibody (red in Figures  1B-1D ). CD11c 1 cells were found in close proximity to the airway wall of shamsensitized ( Figure 1B ) and allergensensitized mice on Day 15, before allergen exposure ( Figure 1C ). CD11c 1 cells in tissue sections from allergen-sensitized mice showed evidence of positive CD41 staining ( Figure 1C) ; furthermore, individual platelets could be distinguished surrounding CD11c 1 cells ( Figure 1D ). No difference in the number of CD11c 1 cells was apparent between sham-sensitized and allergensensitized mice before allergen exposure (0 h) on Day 15 around the airway walls ( Figure 1E ). Twenty-four hours after allergen exposure (on Day 16), a significant increase in CD11c 1 cell localization was observed localized to the airway wall of allergen-sensitized mice (P , 0.05) ( Figure 1E ). Interestingly, there was also a significant increase in the incidence of platelets colocalized to CD11c 1 cells around the airway walls in allergen-sensitized mice when compared with sham-sensitized mice before allergen exposure (0 h) on Day 15 (shamsensitized vs. OVA-sensitized; P , 0.05) ( Figure 1F ). This colocalization around the airway wall was further increased 24 hours after allergen exposure on Day 16 (sham-sensitized vs. OVA-sensitized; P , 0.01) ( Figure 1F) . Thus, the observation that platelets colocalized with tissue CD11c 1 cells in response to allergen sensitization suggests that platelet activation (e.g., migration, intercellular communication) occurs and may therefore be relevant during allergen recognition by APCs.
Induction of Temporary Thrombocytopenia at Time of Allergen Sensitization
To evaluate whether platelets are involved in allergen sensitization, we developed a novel protocol to make mice temporarily thrombocytopenic during, but importantly restricted to, the distinct period of allergen sensitization rather than during allergen exposure, as previously reported (3, 10-12, 24, 25, 27) . Platelet depletion using an antiglycoprotein Iba antibody induced a 95% reduction of circulating platelets when administered 24 hours before each intraperitoneal administration of OVA Histological analysis revealed the colocalization of CD11c 1 cells and platelets in lung tissue of allergen-sensitized mice before allergen exposure, and our previous data revealed that the accumulation of platelets into the lung after sensitization was dependent on platelet FceRI (16) . Furthermore, we have previously reported that the expression of FceRI on platelets is increased in mice sensitized to allergen compared with sham-sensitized mice (16) . We therefore examined the effect of platelet depletion at the time of sensitization on the expression of platelet FceRI. Using a gating strategy to identify CD41 events by flow cytometry (Figure 2B ), we identified FceRI on the surface of these cells (Figures 2C-2E) . On Day 15, a significant increase in the proportion of platelets expressing FceRI was observed in allergen-sensitized mice compared with sham-sensitized mice in the absence of allergen exposure (P , 0.01) ( Figure 2F ). This distinct population of platelets expressing FceRI was significantly suppressed in allergen-sensitized mice depleted of platelets during the sensitization period compared with allergen-sensitized mice administered control IgG antibody (P , 0.01) ( Figure 2F ). Thus, given that only a distinct population of platelets express FceRI, and given that the murine platelet life-span is 3-4 days, the process of sensitization to allergen continues to directly affect the manifestation of this platelet population or bone marrow megakaryocytes sometime after the platelet population temporally associated with the administration of allergen would have been consumed. These data suggest that the sensitization process toward allergen directly affects the phenotype of circulating platelets.
Temporary Thrombocytopenia at Time of Allergen Sensitization Inhibits Pulmonary Leukocyte Recruitment in Response to Subsequent Allergen Exposure
On Days 15, 16, and 17, mice were exposed to aerosolized allergen (OVA). Twenty-four hours after final allergen exposure (Day 18), BAL was performed to enumerate pulmonary leukocyte recruitment. Allergen exposure induced significant pulmonary recruitment of inflammatory cells in allergen-sensitized mice compared with sham-sensitized mice (eosinophils, P , 0.001 [ Figure 3A] ; macrophages, P , 0.05 [ Figure 3B ]; neutrophils, P , 0.05 [ Figure 3C ]; and lymphocytes, P , 0.01 [ Figure 3D] ). The presence of thrombocytopenia at the time of allergen sensitization in mice suppressed leukocyte recruitment compared with allergen-sensitized mice administered the nondepleting control IgG antibody (eosinophils, P , 0.01 [ Figure 3A] ; macrophages, P , 0.05 [ Figure 3B] ). Lymphocyte recruitment was also suppressed, but not to a significant degree ( Figure 3D ), whereas neutrophil recruitment was not altered in plateletdepleted animals ( Figure 3C ). 
ORIGINAL RESEARCH Temporary Thrombocytopenia at the Time of Allergen Sensitization Suppresses IgE and IL-4 Production
We next investigated whether platelet depletion during the phase of allergen sensitization might affect the immune phenotype of the mice. IL-4, IL-5, and IFN-g concentrations in BAL fluid, as well as IgE in serum, were measured from samples taken on Day 18, 24 hours after the last day of allergen exposure on Day 17. Significantly increased concentrations of IgE, IL-4, and IL-5, but not IFN-g, were observed in allergen-sensitized mice compared with sham-sensitized mice (IgE, P , 0.05 [ Figure 4A ]; IL-4, P , 0.05 [ Figure 4B ]; IL-5, P , 0.05 [ Figure 4C] ). Temporary thrombocytopenia during the period of allergen sensitization resulted in suppression of IgE production (P , 0.05 [ Figure 4A ]) and IL-4 production (P , 0.05 [ Figure 4B ]), whereas IL-5 production ( Figure 4C ) and IFN-g were not affected ( Figure 4D ). These data nonetheless suggest that platelets directly affect the Th2 sensitization process during this period.
Temporary Thrombocytopenia during the Sensitization Process Inhibits Pulmonary CD11c
1 Cell Recruitment
We have previously reported that in noninflamed tissue, a small number of platelets reside in lung tissue, and 90% of these are attached to mononuclear cells (16 [16] ). Furthermore, this increased accumulation of platelets extravascularly and their association with mononuclear cells were suppressed in mice deficient in functional FceRI, suggesting that platelet localization to lung-resident mononuclear cells in response to allergen sensitization was dependent on platelet activation via FceRI (16) . Given that platelet FceRI expression is significantly decreased in animals made temporarily thrombocytopenic at the time of allergen sensitization ( Figure 2F ), we assessed whether the increase in CD11c 1 cell numbers in the lungs after allergen exposure ( Figure 1F ) was platelet dependent. Lungs were taken from either sham-sensitized or allergen-sensitized mice at either 0 (Day 15) or 24 hours (Day 16) after allergen exposure, and they were processed into a single-cell suspension to allow quantitative flow cytometry of CD11c 1 events with the use of a fixed number of fluorescent beads to assist with accurate enumeration ( Figure 5A ). In accordance with immunohistochemistry of mouse lungs, a significant increase in the number of CD11c 1 cells was observed 24 hours after allergen exposure on Day 16 in allergen-sensitized mice compared with sham-sensitized mice (P , 0.001) ( Figure 5C ). This was a result of secondary allergen exposure rather than the sensitization process, because no increase in CD11c 1 cells was observed before allergen exposure (0 h) on Day 15 ( Figure 5B ). This accumulation was reduced in allergensensitized mice rendered temporarily thrombocytopenic during the period of allergen sensitization (P , 0.05) ( Figure 5C ), suggesting that allergen-exposed platelets are necessary for pulmonary CD11c 1 cell recruitment.
Discussion
We have shown, for the first time to our knowledge, that platelets are causal in the initial processing of allergen in vivo. The temporary depletion of platelets during the initial sensitization period suppressed inflammatory cell recruitment upon subsequent allergen exposure (aerosol allergen challenge) (Figure 3) , and this correlated with an inhibition of IL-4 synthesis and IgE production (Figure 4) . We have previously reported that allergen can induce platelet motility and migration into lungs after allergen exposure (16), whereas others have also reported activation of platelets via IgE-dependent mechanisms (18) . As shown in the present study, one consequence of platelet accumulation in tissue in response to allergen is platelet colocalization with CD11c 1 cells, a phenomenon that occurs before subsequent allergen exposure (Figure 1 ). Given the reduction in the Th2 response, we conclude that the actions of platelets during allergen sensitization are probably delivered via an IgE-dependent FceRI process to interact with lung APCs, such as CD11c
1 DCs, to process allergen signaling with T cells in bronchial lymph nodes, although the data in the present study are restricted to CD11c 1 cells rather than specifically DCs that express the CD11c antigen. We note that in contrast to other studies (24), we did not observe effects of platelet depletion on IgE and Th2 cytokine production after allergen exposure, either acutely (3 d of allergen exposure) or chronically (8 wk of allergen exposure), and the effects of platelets on Th2 cytokine production are constrained temporally to the time of allergen sensitization (3, 13, 25) .
The phenomenon of allergen-exposed platelets being necessary for pulmonary CD11c 1 cell recruitment after secondary allergen exposure is unlikely to be due to an inability of the restored platelet population to efficiently recruit CD11c 1 cells from the circulation, because our previous studies have revealed that platelets from non-allergen-sensitized mice retain their ability to recruit leukocytes (3). Furthermore, neutrophil recruitment to the lungs was not influenced by platelet depletion at the time of allergen sensitization, even though it is well understood that pulmonary neutrophil recruitment is dependent on intravascular interactions with platelets (10, 27) .
It remains to be understood why professional APCs such as DCs might require platelet interactions for more efficient processing of allergen in vivo. DCs also express FceRI in different conformations with cross-linked IgE; yet, it has been reported that IgE-mediated activation of DCs in allergic Th2-type inflammation might be immune-regulatory rather than proinflammatory (26, 28) . Clearly, IgE/FceRI-mediated antigen presentation by DCs is considered to be a critical event in the priming of Th2-type cells (29) , but recent evidence suggests that this response is dependent on low antigen concentrations rather than on receptor signaling per se (30) . T-cell activities induced after IgE/FceRI-dependent processes by DCs have been reported not to develop as efficiently into Th2-type effector cells as those generated via an IgE/FceRIindependent process (31) . The process by which DCs process antigen and elicit a Th2-type response is complex and might therefore involve other cell types, including platelets that have been implicated in the innate response and express FceRI, CD23, and other immunoglobulin receptors, as well as Toll-like receptors (2) . Indeed, it has been reported that platelet communication with APCs is regulated by CD40/CD40L interactions, and this might be an important component of DC communication with T cells in the draining lymph nodes after platelet activation by allergen (26, 32) . Currently, the understanding of why APCs might require platelets to effect an immune response is incomplete, but perhaps platelet activation by allergen or pathogens via IgE-dependent processes is a more direct innate response with less regulation and control. Two recent studies showed the ability of platelets to modulate the immune response in mouse models of eosinophilic and allergic airway inflammation (33, 34) . The transfer of human platelets restored papain-induced airway eosinophilia on an IL-33-deficient background in mice, supporting a hypothesis that platelets are important in the IL-33-dependent provocation of Th2 immune cells (33) . Furthermore, the platelet-derived Wnt antagonist Dickkopf-1 was reported to be important for Th2-cell cytokine production in a house dust mite model of asthma (34) . The pathways by which platelets might affect sensitization to allergens in patients with asthma has not yet been described, but it is of interest that platelets from patients allergic to D. pteronyssinus have been shown to be activated directly by the specific allergen and not to be activated by other known allergens to which the allergic blood donor was not sensitized (16, 18) . Thus, clinical data are suggestive of an interaction between platelets and the sensitization process.
It is not understood how induced expression of FceRI occurs on circulating platelets (Figure 2 ). The percentage of platelets that express these receptors remains a small subset of the whole platelet population, which might suggest that megakaryocytes residing in the bone marrow are capable of differentiation to ultimately determine the phenotype of subsets of platelets. It is interesting to note, however, that this increase in platelet FceRI expression is suppressed in mice subjected to temporary thrombocytopenia at the time of allergen sensitization ( Figure 2) . The life-span of murine platelets is between 3 and 4 days; yet, the recording in the present study was done when the platelet population had fully recovered, suggesting that there is establishment of immune memory in a subset of megakaryocytes to continue producing a population of platelets with increased expression of FceRI.
To conclude, the initial processing of antigen in naive animals requires the involvement of platelets and leads to increased production of allergenresponsive platelets perhaps transmitted from megakaryocytes during thrombopoiesis. These findings support earlier clinical data regarding the ability of platelets to become activated by specific allergens to which individual patients with allergy become sensitized (16, 18, 35) . These platelets respond by recruiting to organs that are exposed to the external environment and migrate to prime resident APCs for an efficient antigen-dependent immune response after subsequent exposure to allergen. n 
